Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-179795
Filing Date
2025-08-13
Accepted
2025-08-13 16:00:47
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20250630.htm   iXBRL 10-Q 2096747
2 EX-31.1 enta-ex31_1.htm EX-31.1 12404
3 EX-31.2 enta-ex31_2.htm EX-31.2 12340
4 EX-32.1 enta-ex32_1.htm EX-32.1 13368
5 GRAPHIC img217886331_0.jpg GRAPHIC 412540
  Complete submission text file 0001193125-25-179795.txt   8788049

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20250630.xsd EX-101.SCH 927905
65 EXTRACTED XBRL INSTANCE DOCUMENT enta-20250630_htm.xml XML 1468638
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 251211273
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)